The World Health Organization (WHO) has identified the strain of Ebola that resurfaced in the Democratic Republic of Congo. 

It says it is the Zaire strain of the virus and that vaccinations of health workers may start as early as Wednesday.

WHO's Deputy Director for Emergency Preparedness and Response, Peter Salama, gave the results of genetic sequencing in a tweet.

He said that analysis showed it was a new outbreak in North Kivu province.

“We can start using rVSV-ZEBOV vaccine as early as tomorrow.”

The experimental vaccine, which is manufactured by Merck, proved successful during its first wide-scale usage against an outbreak of Zaire virus on the other side of Congo in the northwest that was declared over less than two weeks ago after killing 33.

Also Read: Man Shocked To Death In Kaduna While Trying To Steal Power Supply Cable

The experimental vaccine, which is manufactured by Merck, proved successful during its first wide-scale usage against the outbreak in the northwest.

Movie ticket

More than 3,000 doses remain in stock in the capital Kinshasa, allowing authorities to quickly deploy it to the affected areas near the Ugandan border.

The vaccine normally needs to be kept at 80 degrees Celsius below freezing (minus 112 Fahrenheit), although it can be stored for a couple of weeks at just above freezing.

If you enjoyed reading this and our other stories, please, share with friends and loved ones.

SHAYI-SHAYI GANG: THE SHOCKING CONFESSIONS OF DRUG ADDICTS IN KANO